VFA
AMED

Valeo Financial Advisors’s Amedisys AMED Stock Holding History

Valeo Financial Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29
Closed -$8K – 570
2021
Q1 		$8K Hold
29
– – ﹤0.01% 1406
2020
Q4 		$9K Hold
29
– – ﹤0.01% 1212
2020
Q3 		$7K Sell
29
-14
-33% -$3.18K ﹤0.01% 1157
2020
Q2 		$9K Buy
43
+3
+8% +$560 ﹤0.01% 1303
2020
Q1 		$8K Buy
40
+3
+8% +$534 ﹤0.01% 1156
2019
Q4 		$6K Hold
37
– – ﹤0.01% 1218
2019
Q3 		$5K Hold
37
– – ﹤0.01% 1184
2019
Q2 		$4K Buy
+37
New +$4.39K ﹤0.01% 1240

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Valeo Financial Advisors's AMED Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Amedisys (AMED) in Q2 2021, closing a stake of 29 shares — an estimated $8K sold.

Valeo Financial Advisors first reported a position in AMED in Q2 2019 and held it in 8 quarters. The position peaked at $9K in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 29 Amedisys shares in Q2 2021, an estimated $8K.
  • Valeo Financial Advisors first reported a position in Amedisys in Q2 2019 and held it in 8 quarters.
  • Valeo Financial Advisors's Amedisys position peaked at $9K in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.